SCHEMBL3914871

SCHEMBL3914871

COc1ccc(CNS(=O)(=O)c2ccc(Br)cc2)cc1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.76
TSHR P16473 2/20 0.68
SMN1; SMN2 Q16637 2/20 0.68
LMNA P02545 2/20 0.68
HTT P42858 1/20 0.68
CYP19A1 P11511 2/20 0.67
EGFR P00533 1/20 0.63
ERBB2 P04626 1/20 0.63
USP2 O75604 1/20 0.62
OPRK1 P41145 1/20 0.60
KDM4E B2RXH2 1/20 0.59
IDO1 P14902 1/20 0.58
PKM P14618 1/20 0.58
GRK2 P25098 1/20 0.57
MEN1 O00255 1/20 0.56
NPC1 O15118 1/20 0.56
GAA P10253 1/20 0.56
MAPT P10636 1/20 0.56
RAB9A P51151 1/20 0.56
KMT2A Q03164 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19636581 0.86 ALDH1A1 (1.00) ALDH1A1TSHRSMN1; SMN2LMNAHTT
SCHEMBL13310570 0.86 ALDH1A1 (0.78) ALDH1A1TSHRSMN1; SMN2LMNAHTT
SCHEMBL12793674 0.86 ALDH1A1 (0.78) ALDH1A1TSHRSMN1; SMN2LMNAHTT
SCHEMBL29259796 0.85 ALDH1A1 (0.86) ALDH1A1SMN1; SMN2EGFRERBB2PKM
SCHEMBL1893565 0.85 ALDH1A1 (0.76) ALDH1A1TSHRSMN1; SMN2LMNAHTT
SCHEMBL4915517 0.85 ALDH1A1 (0.76) ALDH1A1TSHRSMN1; SMN2LMNAHTT
SCHEMBL6272107 0.85 ALDH1A1 (0.76) ALDH1A1TSHRSMN1; SMN2LMNAHTT
SCHEMBL13419650 0.85 ALDH1A1 (0.76) ALDH1A1TSHRSMN1; SMN2LMNAHTT
SCHEMBL120702 0.84 ALDH1A1 (1.00) ALDH1A1TSHRSMN1; SMN2LMNAHTT
SCHEMBL3659182 0.84 ALDH1A1 (0.88) ALDH1A1TSHRSMN1; SMN2LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035372-A1 MODULATORS OF THE HISTAMINE H3-RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2009-03-18 EP disclosed
WO-2008005338-A1 MODULATORS OF THE HISTAMINE H3-RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2008-01-10 WO disclosed